Collin Blakely

MD PhD

Thoracic medical oncologist
Award-winning clinical researcher

Dr. Collin Blakely is a medical oncologist who specializes in lung cancer. In addition to treating patients, he conducts research focused on understanding the cellular and molecular mechanisms underlying lung cancer resistance to targeted therapies. His goal is to translate laboratory findings into new treatments.

Blakely received his bachelor's degree in molecular and cellular biology from the University of Washington. He attended the Medical Scientist Training Program at the Perelman School of Medicine, earning both his medical and doctoral degrees. He completed his fellowship training in medical oncology at UCSF.

  • Education

    University of Pennsylvania Perelman School of Medicine, 2007

  • Residencies

    Hospital of the University of Pennsylvania, Internal Medicine, 2009

  • Fellowships

    UCSF Medical Center, Medical Oncology, 2011

  • Board Certifications

    Internal Medicine, American Board of Internal Medicine

    Medical Oncology, American Board of Internal Medicine

My approach is to learn from every patient and to continually push the envelope in the development of new treatments.

Conditions I specialize in

Clinics I work with

View map

Thoracic Surgery and Oncology Clinic

See both of our San Francisco locations.

(415) 885-3882

My reviews

4.8

Overall Experience
94 Ratings
About our process
Nov 22, 2023
Satisfied
Nov 17, 2023
He listened to and asked about how I was doing.
Oct 25, 2023
Very pleased with him
Oct 18, 2023
Everyone I dealt with there were top notch professionals. I can't think of anything that could be improved.
Sep 15, 2023
Dr. Blakely and his team are excellent! He is caring informative provides suggestions etc. etc. His follow up is excellent as well! I am so very blessed and thankful to have him as my oncologist!!
Aug 25, 2023
I would prefer in an in-office appointment. I've never seen Dr. Blakely face to face or have had the benefit of faving him go over images with me.
Jul 20, 2023
Good
Jul 16, 2023
pleasant
Jun 09, 2023
So grateful Dr Blakely is my Dr and part of my medical team.
Apr 15, 2023
There were no negative points.
Apr 13, 2023
I felt I was part of my car. Very thorough explanations of my condition. He offered his continued service in the future.
Mar 16, 2023
Probably one of the best.
Feb 09, 2023
Dr. Blakely is awesome
Feb 01, 2023
Very good
Jan 14, 2023
The experience is only positive. Clear information on treatment issues without unnecessary information
Dec 29, 2022
Dr. Blakely has been very involved in my care. He always ensure that concerns are addressed immediately.
Dec 01, 2022
Dr. Blakely has always been kind informative and listens to my concerns.
Oct 27, 2022
Dr. Blakely and his team are courteous informed and always helpful.
Apr 20, 2022
Dr Blakely is my oncologist and one of the best physicians I have had in my life. He is extremely knowledgeable caring and takes time with his patients. I am so thankful he has handled my case. Thank you!!

Selected research

Decorative Caduceus

Capmatinib Plus Trametinib for the Treatment of Metastatic Non-small Cell Lung Cancer With MET ...

Proportion of participants who experience a DLT for capmatinib in combination with trametinib in Phase I. A dose limiting toxicity (DLT) will be defined as any adverse event that are considered by the investigator to be at least p...

Recruiting

Decorative Caduceus

Osimertinib Alone or With Chemotherapy for EGFR-Mutant Lung Cancers

As the primary endpoint for the treatment comparison, it is the duration of time from randomization to the time of disease progression (in the CNS or systemically) or death. In addition, as a secondary endpoint, PFS is measured fr...

Recruiting

Decorative Caduceus

Study of Avutometinib (VS-6766) + Adagrasib in KRAS G12C NSCLC Patients

Assessment of Dose-limiting toxicities (DLTs)

Recruiting

Contact me

Share